Scilex Holding (SCLX) Return on Invested Capital (2022 - 2025)
Scilex Holding (SCLX) posted quarterly Return on Invested Capital of 0.03% for Q4 2025, up 2.0% year-over-year from 0.03% in Q4 2024, and up 74.88% on a QoQ basis from 0.02% in Q3 2025.
Scilex Holding (SCLX) Return on Invested Capital (2022 - 2025) Analysis & Trends
Scilex Holding (SCLX) has reported Return on Invested Capital for 4 consecutive years, with 0.03% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Invested Capital rose 2.0% year-over-year to 0.03%; the TTM figure through Dec 2025 stood at 0.03% (up 2.0% YoY), while the FY2025 annual figure was 0.02%, up 2.0% from the prior year.
- Return on Invested Capital came in at 0.03% for Q4 2025 at Scilex Holding, up from 0.02% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.1% in Q3 2023, with the low at 0.04% in Q2 2023.
- Average Return on Invested Capital over 4 years is 0.01%, with a median of 0.01% recorded in 2024.
- The largest YoY upside for Return on Invested Capital was 5 bps in 2024 against a maximum downside of 10 bps in 2024.
- Year by year, Return on Invested Capital stood at 0.01% in 2022, then jumped by 259 bps to 0.02% in 2023, then tumbled by 69 bps to 0.01% in 2024, then soared by 361 bps to 0.03% in 2025.
- According to Business Quant data, Return on Invested Capital over the past three periods registered 0.03%, 0.02%, and 0.01% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.00% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.00% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.00% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.00% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.00% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.03% |
| Sep 30, 2025 | 0.02% |
| Jun 30, 2025 | 0.01% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.01% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | 0.01% |
| Dec 31, 2023 | 0.02% |
| Sep 30, 2023 | 0.10% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | 0.01% |